NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON

Vendor Intelligence Report: LiliPeptide

Published 12 Nov 2026. 37-page investigative report on who is behind LiliPeptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

LiliPeptide is a per-product, not blanket, call. Across 344 Finnrick lab tests, the vendor records 247 pass and 96 fail calls, for a 72% overall pass rate. The catalog is uneven: GHK-Cu is the clearest positive signal, retatrutide has useful depth but still needs current lot proof, and TB-500 and CJC-1295 sit at the weak end. Ratings also compress under stricter scoring, so the public percentage should be read as field signal, not pharmaceutical assurance.

The identity file is more complicated than the storefront suggests. The vendor is listed as U.S.-located, but public-source work did not establish a U.S. legal entity, verified Hong Kong company, natural-person UBO or named QA/batch-release authority. The supported operating footprint is China/Hong Kong sales infrastructure, with a typo-spelled official domain, a correctly spelled Peptide-Sources catalogue, and a sister storefront tied by reused PeptSlim policy text.

The report also finds a traceability gap. LiliPeptide publishes seven Janoshik reports from July 2025, all marked Batch: Unknown, while ISO/GMP and HPLC-each-batch claims appear without certificate numbers, audited facility scope or release-personnel verification. A Nuoao/shop910 template trail points to supplier or reseller-launch infrastructure, but not proven ownership.

Reputation evidence is mixed: buyers report real deliveries, but Trustpilot and Reddit also describe post-payment customs, insurance, permit, testing and package-change demands. The issue is not proven non-delivery; it is that a live ordering flow appears to coexist with weak official-channel controls and impersonation exposure.

Inside the full report:

  • Appendix A per-product pass/fail record and methodology-divergence charts for all 15 tested products
  • Domain, RDAP, DNS and certificate-timeline analysis for lilipetide.com, lilipeptide.com and ElitePeptide66
  • COA review of the seven July 2025 Janoshik reports, including batch and verification-key limitations
  • Nuoao / Peptidetr / shop910 supplier-template mapping, including hidden contact page artifacts
  • Trustpilot, Reddit, Skool, TikTok and affiliate-directory captures showing fee-escalation, referral and sales-channel patterns

Risk assessment

  • Weak-product quality risk — high: TB-500 (22.31%), NAD+ (23.6%), CJC-1295 (25.33%), MOTS-c (37.43%) and CJC-IPA (44.28%) are poor LiliPeptide choices without exact-lot independent testing.
  • Post-payment fee-escalation risk — high: Trustpilot and Reddit describe customs, insurance, permit, testing and package-change demands after payment; not proven vendor-controlled but tied to the buyer flow.
  • Corporate-identity / UBO opacity risk — high: No verified U.S. or Hong Kong entity or natural-person UBO was established; Lilitide/Lilitai returned zero in the HK mirror.
  • Brand-confusion and copycat-channel risk — high: The typo official domain, correct-spelling Peptide-Sources store, ElitePeptide66/PeptSlim overlap and WhatsApp funnels lack an authoritative official-channel map.
  • Batch-traceability risk — medium: Public COAs are seven July 2025 Janoshik images, all marked Batch: Unknown, with no lot lookup for current vials.
  • Off-site payment and dispute-recourse risk — medium: Some orders are paid via WhatsApp/Wise or other off-site routes; payment page is empty and no merchant descriptor was recovered.
  • Unverified manufacturing / QA-claim risk — medium: ISO 9001, GMP/research-grade and HPLC/MS-each-batch claims appear without certificate details, facility scope or named QA/batch-release personnel.
  • Affiliate-promotion risk — medium: A Reddit user claimed a referral scheme, Mia Becky sells in Skool communities and an affiliate-style directory lists LiliPeptide, but no formal terms were found.